Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1373533Generated: October 25, 2026

Sodium triacetoxyborohydride → 7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one

https://huagongshe.com/reaction/1373533

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium triacetoxyborohydrideHCID 5049666—
Reactant1-(5-Chloro-2-isopropoxy-phenyl)-piperazineHCID 21073166—
Reactant4-((7-Oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)oxy)butanalHCID 21073377—
Solvent1,1-DichloroethaneHCID 6365—
SolventEthyl AcetateHCID 8857—
Product7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-oneHCID 2107371145.4%

Reaction Steps

To a suspension of 4-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde (0.241 g, 1.02 mmol, 1 eq) and 1-(5-chloro-2-isopropoxy-phenyl)-piperazine (0.382 g, 1.13 mmol, 1.1 eq) in dichloroethane (5 mL) was added NaBH(OAc)3 (0.583 g, 2.75 mmol, 2.67 eq). The slurry was allowed to stir overnight at room temperature (18 h). Analysis by HPLC showed reaction mostly complete. The mixture was diluted with EtOAc and quenched with saturated NaHCO3. The organic phase was then washed with brine, dried over Na2SO4, filtered and evaporated in vacuo. Purification by silica gel chromatography (100% EtOAc) followed by formation of the HCl salt using 1N HCl in ether provided the title compound (0.219 g, 25%). MS: APCI: M+1: 473.2 (Exact Mass: 472.22).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07160888B2
Source datasetuspto-grants-2007_01
ORD IDord-dd37439ed99643c7a02d08a9e358a307
Source noteuspto-grants-2007_01